China Shifts AI Strategy Toward Stock Market Investment Over State Subsidies
Beijing's pivot from direct government funding to equity-market mechanisms in the AI sector has direct implications for U.S. semiconductor export controls and ongoing Congressional debates over...
China is restructuring its approach to artificial intelligence investment by directing capital into domestic AI equities rather than relying primarily on state subsidies and government grants, according to a report published by Bloomberg on August 9, 2026. The strategic shift represents a measurable change in how Beijing allocates resources in its competition with the United States for leadership in chip manufacturing and AI development.
The policy change carries direct relevance to U.S. federal legislation and executive action. Congress passed the CHIPS and Science Act (Public Law 117-167) in August 2022, authorizing approximately $52.7 billion in federal spending to bolster domestic semiconductor manufacturing and research, with the stated purpose of countering Chinese technological advances. The Commerce Department's Bureau of Industry and Security has additionally issued a series of export control rules — including the October 2022 and October 2023 semiconductor export restrictions — specifically targeting the transfer of advanced chip technology to Chinese entities. Those rules are publicly available in the Federal Register.
The Biden administration's Executive Order 14105, signed August 9, 2023, further restricted outbound U.S. investment in Chinese semiconductor, quantum computing, and AI sectors. The order directed the Treasury Department to establish a notification and prohibition framework for covered transactions. Treasury's proposed implementing rules were published in the Federal Register (Vol. 88, No. 213). Whether the current administration has modified, extended, or rescinded any component of that order as of August 2026 is not confirmed in publicly available records reviewed for this report.
On Capitol Hill, the Senate Commerce Committee and the House Select Committee on the Chinese Communist Party have each held hearings in the 119th Congress examining U.S.-China technology competition. Specific legislative proposals introduced in the current Congress addressing AI investment restrictions are recorded in the Congressional Record, though final passage status of any such measures was not confirmed in the source material available for this report.
What remains unknown is the precise volume of Chinese capital being redirected into AI equities, which Chinese firms are receiving those investments, and whether any of those firms maintain U.S.-listed securities or partnerships with American companies subject to existing export controls. The Treasury Department's Office of Foreign Assets Control (OFAC) and the Committee on Foreign Investment in the United States (CFIUS) annual reports would be the relevant public documents to consult for that data. The Bloomberg report did not specify the total dollar figure of the redirected investment or name the specific Chinese government entities authorizing the strategy.